PCN6 EVALUATING THE QUALITY AND RISK OF BIAS IN OVERALL SURVIVAL OUTCOMES FROM NON-RANDOMISED CAR T-CELL THERAPY PIVOTAL TRIALS
Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.203
https://www.valueinhealthjournal.com/article/S1098-3015(19)32581-1/fulltext
Section Title :
Section Order :
10155
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32581-1&doi=10.1016/j.jval.2019.09.203